Journal Article
. 2007 Feb; 99(3):196-205.
doi: 10.1093/jnci/djk028.

Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy

Dawn Hershman 1 Alfred I Neugut  Judith S Jacobson  Jian Wang  Wei-Yann Tsai  Russell McBride  Charles L Bennett  Victor R Grann  
  • PMID: 17284714
  •     92 citations


Background: Recently, increasing numbers of women receiving adjuvant chemotherapy for breast cancer have also received granulocyte colony-stimulating factors (G-CSFs) or granulocyte-macrophage colony-stimulating factors (GM-CSFs). Although these growth factors support chemotherapy, their long-term safety has not been evaluated. We studied the association between G-CSF use and incidence of leukemia in a population-based sample of breast cancer patients.

Methods: Among women aged 65 years or older in the Surveillance, Epidemiology, and End Results-Medicare database who were diagnosed with stages I-III breast cancer from January 1, 1991, to December 31, 1999, we identified those who received G-CSF or GM-CSF concurrently with chemotherapy. We used Cox proportional hazards models to estimate hazard ratios for the association of treatment with G-CSF or GM-CSF and subsequent (through December 31, 2003) diagnosis of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). All statistical tests were two-sided.

Results: Of 5510 women treated with chemotherapy, 906 (16%) received G-CSF or GM-CSF therapy, and 64 (1.16%) were subsequently diagnosed with either MDS or AML before a cancer recurrence. Use of G-CSF and GM-CSF was associated with more recent diagnosis, younger age, urban residence, fewer comorbidities, receipt of radiation therapy, positive lymph nodes, and cyclophosphamide treatment. Of the 906 patients who were treated with G-CSF, 16 (1.77%) developed AML or MDS; of the 4604 patients not treated with G-CSF, 48 (1.04%) developed AML or MDS. The hazard rate ratio for AML or MDS among those treated with G-CSF or GM-CSF compared with those who were not was 2.14 (95% confidence interval [CI] = 1.12 to 4.08). AML or MDS developed within 48 months of breast cancer diagnosis in 1.8% of patients who received G-CSF or GM-CSF but only in 0.7% of patients who did not (hazard ratio = 2.59, 95% CI = 1.30 to 5.15).

Conclusions: The use of G-CSF was associated with a doubling in the risk of subsequent AML or MDS among the population that we studied, although the absolute risk remained low. Even if this association is confirmed, the benefits of G-CSF may still outweigh the risks. Meanwhile, however, G-CSF use should not be assumed to be risk free.

Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis.
M Debled, N Houédé, +4 authors, Louis Mauriac.
Br J Cancer, 2007 Nov 15; 97(12). PMID: 18000502    Free PMC article.
Prospective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndrome.
Blaine W Robinson, Nai-Kong V Cheung, +4 authors, Carolyn A Felix.
Blood, 2008 Jan 16; 111(7). PMID: 18195096    Free PMC article.
Canadian supportive care recommendations for the management of neutropenia in patients with cancer.
C T Kouroukis, S Chia, +4 authors, J Mikhael.
Curr Oncol, 2008 Mar 05; 15(1). PMID: 18317581    Free PMC article.
Second cancers in patients with the Ewing sarcoma family of tumours.
Fariba Navid, Catherine Billups, +2 authors, Carlos Rodriguez-Galindo.
Eur J Cancer, 2008 Mar 21; 44(7). PMID: 18353632    Free PMC article.
Dietary antioxidants protect hematopoietic cells and improve animal survival after total-body irradiation.
Chris Wambi, Jenine Sanzari, +7 authors, Ann R Kennedy.
Radiat Res, 2008 Mar 28; 169(4). PMID: 18363433    Free PMC article.
Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis.
Athanasia D Panopoulos, Stephanie S Watowich.
Cytokine, 2008 Apr 11; 42(3). PMID: 18400509    Free PMC article.
Highly Cited. Review.
Patterns of mortality after prolonged follow-up of a randomised controlled trial using granulocyte colony-stimulating factor to maintain chemotherapy dose intensity in non-Hodgkin's lymphoma.
A R Clamp, W D J Ryder, +2 authors, J A Radford.
Br J Cancer, 2008 Jul 03; 99(2). PMID: 18594529    Free PMC article.
Therapy-related myeloid leukemia.
Lucy A Godley, Richard A Larson.
Semin Oncol, 2008 Aug 12; 35(4). PMID: 18692692    Free PMC article.
Severe events in donors after allogeneic hematopoietic stem cell donation.
Joerg Halter, Yoshihisa Kodera, +7 authors, Alois Gratwohl.
Haematologica, 2008 Dec 09; 94(1). PMID: 19059940    Free PMC article.
Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.
Lorenzo Gianni, Shari Gelber, +9 authors, Aron Goldhirsch.
Eur J Cancer, 2008 Dec 09; 45(4). PMID: 19062268    Free PMC article.
Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues.
Nobuko Hijiya, Kirsten K Ness, Raul C Ribeiro, Melissa M Hudson.
Cancer, 2008 Dec 17; 115(1). PMID: 19072983    Free PMC article.
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimens.
Dushyant Verma, Susan O'Brien, +8 authors, Farhad Ravandi.
Cancer, 2008 Dec 18; 115(1). PMID: 19090005    Free PMC article.
Breast cancer and the immune system.
Leanna J Standish, Erin S Sweet, +5 authors, Carolyn Torkelson.
J Soc Integr Oncol, 2009 Jan 13; 6(4). PMID: 19134448    Free PMC article.
Ten-year follow-up of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte-colony-stimulating factor and dexamethasone.
Karen Quillen, Phyllis Byrne, Yu Ying Yau, Susan F Leitman.
Transfusion, 2009 Feb 27; 49(3). PMID: 19243544    Free PMC article.
Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: a feasibility study.
Xiaoyan Wang, George Hripcsak, Marianthi Markatou, Carol Friedman.
J Am Med Inform Assoc, 2009 Mar 06; 16(3). PMID: 19261932    Free PMC article.
Highly Cited.
Adjuvant chemotherapy for early breast cancer in the elderly.
Mary Leung, Iulianna Shapira, Thomas Bradley, Daniel R Budman.
Curr Treat Options Oncol, 2009 Apr 11; 10(3-4). PMID: 19360475
A health services research agenda for cellular, molecular and genomic technologies in cancer care.
Louise Wideroff, Kathryn A Phillips, +16 authors, Joan Scott.
Public Health Genomics, 2009 Apr 16; 12(4). PMID: 19367091    Free PMC article.
Acupuncture for chemotherapy-induced neutropenia in patients with gynecologic malignancies: a pilot randomized, sham-controlled clinical trial.
Weidong Lu, Ursula A Matulonis, +10 authors, Richard T Penson.
J Altern Complement Med, 2009 Jun 26; 15(7). PMID: 19552597    Free PMC article.
Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996).
Peter L Greenberg, Zhuoxin Sun, +9 authors, Jacob M Rowe.
Blood, 2009 Jul 01; 114(12). PMID: 19564636    Free PMC article.
Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012).
Marilyn L Slovak, Victoria Bedell, +8 authors, Wendy Stock.
Breast Cancer Res Treat, 2009 Oct 24; 119(2). PMID: 19851858    Free PMC article.
Drug-induced hematologic syndromes.
David M Mintzer, Shira N Billet, Lauren Chmielewski.
Adv Hematol, 2009 Dec 05; 2009. PMID: 19960059    Free PMC article.
Outcome of allo-SCT for women with MDS or AML occurring after breast cancer therapy.
P Armand, H T Kim, +6 authors, R J Soiffer.
Bone Marrow Transplant, 2010 Feb 16; 45(11). PMID: 20154738    Free PMC article.
Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?
Matti Aapro, Jeffrey Crawford, Didier Kamioner.
Support Care Cancer, 2010 Mar 02; 18(5). PMID: 20191292    Free PMC article.
Current controversies in the management of breast cancer.
I Tusquets, L García-Estévez, +17 authors, A Lluch.
Clin Transl Oncol, 2010 May 14; 12(4). PMID: 20462837
Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition.
Søren M Johnson, Chad D Torrice, +9 authors, Norman E Sharpless.
J Clin Invest, 2010 Jun 26; 120(7). PMID: 20577054    Free PMC article.
The Role of Supportive Therapy in the Era of Modern Adjuvant Treatment - Current and Future Tools.
Rupert Bartsch, Guenther G Steger.
Breast Care (Basel), 2009 Jan 01; 4(3). PMID: 20847876    Free PMC article.
Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.
H Sill, W Olipitz, +2 authors, A Wölfler.
Br J Pharmacol, 2010 Nov 03; 162(4). PMID: 21039422    Free PMC article.
Is Chemoendocrine Treatment without Alternative?
Richard Greil.
Breast Care (Basel), 2008 Jan 01; 3(4). PMID: 21076602    Free PMC article.
Building capacity to assess cancer care in the Medicaid population in New York State.
Francis P Boscoe, Deborah Schrag, +2 authors, Maria J Schymura.
Health Serv Res, 2010 Dec 17; 46(3). PMID: 21158856    Free PMC article.
Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy.
Michael F Press, Guido Sauter, +17 authors, Dennis J Slamon.
J Clin Oncol, 2010 Dec 30; 29(7). PMID: 21189395    Free PMC article.
Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries.
Christopher R Cogle, Benjamin M Craig, Dana E Rollison, Alan F List.
Blood, 2011 May 03; 117(26). PMID: 21531980    Free PMC article.
Congenital neutropenia: diagnosis, molecular bases and patient management.
Jean Donadieu, Odile Fenneteau, +2 authors, Christine Bellanné Chantelot.
Orphanet J Rare Dis, 2011 May 21; 6. PMID: 21595885    Free PMC article.
Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005.
Henry G Kaplan, Judith A Malmgren, Mary K Atwood.
BMC Cancer, 2011 Jun 23; 11. PMID: 21693006    Free PMC article.
Clinical pharmacology of chemotherapy agents in older people with cancer.
Xiaoye He, Stephen J Clarke, Andrew J McLachlan.
Curr Gerontol Geriatr Res, 2011 Aug 17; 2011. PMID: 21845189    Free PMC article.
Effects of granulocyte-colony-stimulating factor on Monosomy 7 aneuploidy in healthy hematopoietic stem cell and granulocyte donors.
Matthew J Olnes, Andrea Poon, +9 authors, Elaine M Sloand.
Transfusion, 2011 Sep 03; 52(3). PMID: 21883270    Free PMC article.
Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline XPD and XRCC3 homozygous polymorphisms.
Hilda Rachel Diamond, Maria Helena Ornellas, +11 authors, Eliana Abdelhay.
J Hematol Oncol, 2011 Sep 29; 4. PMID: 21951951    Free PMC article.
Adjuvant trastuzumab in HER2-positive breast cancer.
Dennis Slamon, Wolfgang Eiermann, +21 authors, Breast Cancer International Research Group.
N Engl J Med, 2011 Oct 14; 365(14). PMID: 21991949    Free PMC article.
Highly Cited.
Second malignancies among elderly survivors of cancer.
Ari M VanderWalde, Arti Hurria.
Oncologist, 2011 Nov 02; 16(11). PMID: 22042787    Free PMC article.
Identifying specific chemotherapeutic agents in Medicare data: a validation study.
Jennifer L Lund, Til Stürmer, +4 authors, Joan L Warren.
Med Care, 2011 Nov 15; 51(5). PMID: 22080337    Free PMC article.
Incidence of acute myeloid leukemia after breast cancer.
Caterina Giovanna Valentini, Luana Fianchi, +3 authors, Livio Pagano.
Mediterr J Hematol Infect Dis, 2012 Jan 06; 3(1). PMID: 22220266    Free PMC article.
Underreporting of myeloid malignancies by United States cancer registries.
Benjamin M Craig, Dana E Rollison, Alan F List, Christopher R Cogle.
Cancer Epidemiol Biomarkers Prev, 2012 Jan 13; 21(3). PMID: 22237987    Free PMC article.
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.
George Fountzilas, Christos Valavanis, +18 authors, Petroula Arapantoni.
J Transl Med, 2012 Jan 14; 10. PMID: 22240029    Free PMC article.
Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy.
Patrick J Roberts, John E Bisi, +7 authors, Norman E Sharpless.
J Natl Cancer Inst, 2012 Feb 04; 104(6). PMID: 22302033    Free PMC article.
Highly Cited.
Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer.
Dawn L Hershman, Elizabeth T Wilde, +4 authors, Alfred I Neugut.
J Clin Oncol, 2012 Feb 09; 30(8). PMID: 22312106    Free PMC article.
Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification.
A S Betof, Z N Rabbani, +10 authors, K L Blackwell.
Br J Cancer, 2012 Feb 16; 106(5). PMID: 22333602    Free PMC article.
The co-presence of deletion 7q, 20q and inversion 16 in therapy-related acute myeloid leukemia developed secondary to treatment of breast cancer with cyclophosphamide, doxorubicin, and radiotherapy: a case report.
Ipek Yonal, Fehmi Hindilerden, +2 authors, Melih Aktan.
J Med Case Rep, 2012 Feb 22; 6. PMID: 22339850    Free PMC article.
A way forward on the medically appropriate use of white cell growth factors.
Thomas J Smith, Bruce E Hillner.
J Clin Oncol, 2012 Mar 01; 30(14). PMID: 22370327    Free PMC article.
Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer.
Jessica Chubak, Onchee Yu, +6 authors, Diana S M Buist.
J Natl Cancer Inst, 2012 May 02; 104(12). PMID: 22547340    Free PMC article.
Functional polymorphisms in xenobiotic metabolizing enzymes and their impact on the therapy of breast cancer.
Rosane Vianna-Jorge, Juliana Simões Festa-Vasconcellos, Sheyla Maria Torres Goulart-Citrangulo, Marcelo Sobral Leite.
Front Genet, 2013 Jan 25; 3. PMID: 23346096    Free PMC article.
Hematopoietic stem cell donation.
Shu-Huey Chen, Tso-Fu Wang, Kuo-Liang Yang.
Int J Hematol, 2013 Feb 20; 97(4). PMID: 23420184
Colony-stimulating factors for febrile neutropenia during cancer therapy.
Charles L Bennett, Benjamin Djulbegovic, LeAnn B Norris, James O Armitage.
N Engl J Med, 2013 Mar 22; 368(12). PMID: 23514290    Free PMC article.
Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.
Lois B Travis, Wendy Demark Wahnefried, +2 authors, Andrea K Ng.
Nat Rev Clin Oncol, 2013 Mar 27; 10(5). PMID: 23529000
Highly Cited. Review.
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.
George Fountzilas, Urania Dafni, +21 authors, Meletios A Dimopoulos.
BMC Cancer, 2013 Mar 30; 13. PMID: 23537287    Free PMC article.
Results from the first decade of research conducted by the Research on Adverse Drug Events and Reports (RADAR) project.
June M McKoy, Matthew J Fisher, +10 authors, Dennis P West.
Drug Saf, 2013 Apr 05; 36(5). PMID: 23553448    Free PMC article.
Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, HER2-positive early breast cancer: results from the BCIRG 006 Study.
Heather-Jane Au, Wolfgang Eiermann, +18 authors, Translational Research in Oncology BCIRG 006 Trial Investigators.
Oncologist, 2013 Jul 03; 18(7). PMID: 23814044    Free PMC article.
Breast cancer survivorship issues.
Daniela Stan, Charles L Loprinzi, Kathryn J Ruddy.
Hematol Oncol Clin North Am, 2013 Aug 07; 27(4). PMID: 23915746    Free PMC article.
Comparison of pegfilgrastim prescribing practice to national guidelines at a university hospital outpatient oncology clinic.
Geralyn E Waters, Patricia Corrigan, Mandy Gatesman, Thomas J Smith.
J Oncol Pract, 2013 Aug 15; 9(4). PMID: 23942922    Free PMC article.
Chemotherapy causes cancer! A case report of therapy related acute myeloid leukaemia in early stage breast cancer.
J Cole Aidan, Nicole R Priddee, James J McAleer.
Ulster Med J, 2013 Oct 02; 82(2). PMID: 24082288    Free PMC article.
Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.
Michael A Pulsipher, Pintip Chitphakdithai, +7 authors, Dennis L Confer.
Blood, 2014 Apr 17; 123(23). PMID: 24735965    Free PMC article.
Second malignancies after breast cancer: The impact of adjuvant therapy.
Chunhui Dong, Ling Chen.
Mol Clin Oncol, 2014 Apr 29; 2(3). PMID: 24772296    Free PMC article.
Long-term inhaled granulocyte macrophage-colony-stimulating factor in autoimmune pulmonary alveolar proteinosis: effectiveness, safety, and lowest effective dose.
Spyros A Papiris, Panagiotis Tsirigotis, +8 authors, Effrosyni D Manali.
Clin Drug Investig, 2014 Jun 04; 34(8). PMID: 24890235
Trial watch: Immunostimulatory cytokines in cancer therapy.
Erika Vacchelli, Fernando Aranda, +6 authors, Lorenzo Galluzzi.
Oncoimmunology, 2014 Aug 02; 3. PMID: 25083328    Free PMC article.
G-CSF utilization rate and prescribing patterns in United States: associations between physician and patient factors and GCSF use.
Gisoo Barnes, Ashutosh Pathak, Lee Schwartzberg.
Cancer Med, 2014 Nov 21; 3(6). PMID: 25410813    Free PMC article.
Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience.
Antonio C Wolff, Amanda L Blackford, +10 authors, Judith E Karp.
J Clin Oncol, 2014 Dec 24; 33(4). PMID: 25534386    Free PMC article.
Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.
Balazs I Bodai, Phillip Tuso.
Perm J, 2015 Apr 23; 19(2). PMID: 25902343    Free PMC article.
Stabilization of bone marrow infiltration by metastatic breast cancer with continuous doxorubicin.
Gaurav Pahouja, Robert Wesolowski, +4 authors, Maryam B Lustberg.
Cancer Treat Commun, 2015 Apr 29; 3. PMID: 25914871    Free PMC article.
Racial and ethnic differences in risk of second primary cancers among breast cancer survivors.
Gregory S Calip, Ernest H Law, Naomi Y Ko.
Breast Cancer Res Treat, 2015 May 28; 151(3). PMID: 26012645    Free PMC article.
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial.
Matteo Lambertini, Paolo Bruzzi, +6 authors, Lucia Del Mastro.
Support Care Cancer, 2015 Aug 27; 24(3). PMID: 26306520
Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer.
Gregory S Calip, Judith A Malmgren, +2 authors, Henry G Kaplan.
Breast Cancer Res Treat, 2015 Oct 10; 154(1). PMID: 26450505    Free PMC article.
The importance of the granulocyte-colony stimulating factor in oncology.
Sînziana Cetean, Călin Căinap, +5 authors, Radu Oprean.
Clujul Med, 2016 Jan 07; 88(4). PMID: 26732055    Free PMC article.
Trial Watch-Immunostimulation with cytokines in cancer therapy.
Erika Vacchelli, Fernando Aranda, +10 authors, Lorenzo Galluzzi.
Oncoimmunology, 2016 Apr 09; 5(2). PMID: 27057468    Free PMC article.
Efficacy and safety of acupuncture for chemotherapy-induced leucopoenia: protocol for a systematic review.
Jiayun Nian, Xu Sun, +6 authors, Ganlin Zhang.
BMJ Open, 2016 May 28; 6(5). PMID: 27231002    Free PMC article.
Am80-GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia-associated infection and mortality.
Lin Li, Xiaotian Qi, +12 authors, Lingtao Wu.
EMBO Mol Med, 2016 Nov 04; 8(11). PMID: 27737899    Free PMC article.
Secondary primary malignancies during the lenalidomide-dexamethasone regimen in relapsed/refractory multiple myeloma patients.
Rouslan Kotchetkov, Esther Masih-Khan, +6 authors, Donna E Reece.
Cancer Med, 2016 Nov 20; 6(1). PMID: 27860411    Free PMC article.
Retrospective survey and evaluation of first-line antibiotics for chemotherapy-induced febrile neutropenia in patients with acute myeloid leukemia.
Naoki Mukoyama, Marie Nakashima, +3 authors, Kazuhiro Mori.
Nagoya J Med Sci, 2017 Mar 18; 79(1). PMID: 28303057    Free PMC article.
Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome.
John Bian, Brian Chen, +4 authors, Charles L Bennett.
J Clin Oncol, 2017 Apr 26; 35(17). PMID: 28441110    Free PMC article.
Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustion.
Shenghui He, Patrick J Roberts, +10 authors, Norman E Sharpless.
Sci Transl Med, 2017 Apr 28; 9(387). PMID: 28446688    Free PMC article.
Clinical Features and Outcomes of 666 Cases with Therapy-Related Myelodysplastic Syndrome (t-MDS).
Mohamed Abd El-Fattah.
Indian J Hematol Blood Transfus, 2018 Feb 06; 34(1). PMID: 29398804    Free PMC article.
Characterization and lymphocyte proliferation activity of an oligosaccharide degraded from Astragalus polysaccharide.
Zhen-Yuan Zhu, Jin-Yu Zhang, +3 authors, Yun Tang.
Medchemcomm, 2017 Jun 14; 8(7). PMID: 30108864    Free PMC article.
Biosimilar Drugs: What Would Be a Reasonable Extrapolation?
Markus A C Gifoni, Gustavo S Fernandes, Roger Chammas.
J Glob Oncol, 2018 Sep 23; 4. PMID: 30241152    Free PMC article.
Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.
Hisham Abdel-Azim, Weili Sun, Lingtao Wu.
Pharmacol Ther, 2019 Aug 31; 204. PMID: 31470030    Free PMC article.
Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony-stimulating factors in older patients with non-Hodgkin lymphoma.
Gregory S Calip, Kellyn M Moran, +7 authors, Brian C-H Chiu.
Cancer, 2018 Dec 15; 125(7). PMID: 30548485    Free PMC article.
Mutation, drift and selection in single-driver hematologic malignancy: Example of secondary myelodysplastic syndrome following treatment of inherited neutropenia.
Tomasz Wojdyla, Hrishikesh Mehta, +5 authors, Marek Kimmel.
PLoS Comput Biol, 2019 Jan 08; 15(1). PMID: 30615612    Free PMC article.
Ultra-Sensitive CSF3R Deep Sequencing in Patients With Severe Congenital Neutropenia.
Maksim Klimiankou, Murat Uenalan, +6 authors, Karl Welte.
Front Immunol, 2019 Mar 21; 10. PMID: 30891028    Free PMC article.
Maximizing Breast Cancer Therapy with Awareness of Potential Treatment-Related Blood Disorders.
Henry G Kaplan, Gregory S Calip, Judith A Malmgren.
Oncologist, 2020 Feb 20; 25(5). PMID: 32073195    Free PMC article.
Treatment Related Acute Myeloid Leukemia in Breast Cancer Survivors: A Single Institutional Experience.
Ilavarasi Vanidassane, Ajay Gogia, Vinod Raina, Ritu Gupta.
Indian J Hematol Blood Transfus, 2019 Aug 08; 35(3). PMID: 31388274    Free PMC article.
[Acute myeloid leukemia secondary to autologous hematopoietic stem cell transplant of angioimmunoblastic T- cell lymphoma: one case report and literatures review].
W J Huang, L Wang, +4 authors, J Y Li.
Zhonghua Xue Ye Xue Za Zhi, 2016 Aug 19; 37(7). PMID: 27535867    Free PMC article.
Pancytopenia: A Rare and Unusual Initial Presentation of Breast Cancer.
Vishal Jindal, Anannya Patwari, Vineel Bhatlapenumarthi, Ahmad D Siddiqui.
Cureus, 2019 May 28; 11(3). PMID: 31131159    Free PMC article.
The prophylactic and therapeutic effects of moxibustion combined with traditional Chinese medicine decoction for treating chemotherapy-induced myelosuppression in early-stage breast cancer: study protocol for a randomized controlled trial.
Yajie Ji, Siyu Li, +19 authors, Xiaohong Xue.
Trials, 2020 Oct 14; 21(1). PMID: 33046128    Free PMC article.
Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma.
Stephen K Gruschkus, David Lairson, +2 authors, Xianglin L Du.
Cancer, 2010 Jul 29; 116(22). PMID: 20665502    Free PMC article.
Comparative effectiveness of white blood cell growth factors on neutropenia, infection, and survival in older people with non-Hodgkin's lymphoma treated with chemotherapy.
Stephen K Gruschkus, David Lairson, +2 authors, Xianglin L Du.
J Am Geriatr Soc, 2010 Sep 16; 58(10). PMID: 20840455    Free PMC article.
The Efficacy of Moxibustion for Breast Cancer Patients with Chemotherapy-Induced Myelosuppression during Adjuvant Chemotherapy: A Randomized Controlled Study.
Yajie Ji, Siyu Li, +12 authors, Xiaohong Xue.
Evid Based Complement Alternat Med, 2021 May 15; 2021. PMID: 33986813    Free PMC article.